Cours Mabvax Therapeutics Holdings Inc Nasdaq
Actions
US55414P7024
Recherche biotechnologique et médicale
CA 2016 | 148 k 132 k | CA 2017 | - | Capitalisation | 14,41 M 12,86 M |
---|---|---|---|---|---|
Résultat net 2016 | -17 M -15,17 M | Résultat net 2017 | -19 M -16,95 M | VE / CA 2016 | 147 x |
Dette nette 2016 | 470 k 419 k | Dette nette 2017 | 2,48 M 2,21 M | VE / CA 2017 | - |
PER 2016 |
-0,93
x | PER 2017 |
-0,25
x | Employés | - |
Rendement 2016 * |
-
| Rendement 2017 |
-
| Flottant | 92,02% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 72 | - | |
Chief Tech/Sci/R&D Officer | 81 | 08/07/14 | |
Paul W. Maffuid
CTO | Chief Tech/Sci/R&D Officer | 68 | 08/07/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 81 | 08/07/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
+17,00% | 124 Md | |
+17,24% | 112 Md | |
+4,05% | 22,94 Md | |
-10,65% | 17,02 Md | |
-16,80% | 16,88 Md | |
-39,94% | 16,87 Md | |
+2,47% | 13,63 Md | |
+26,39% | 11,61 Md | |
+102,94% | 10,31 Md |